Background illustration for clinical trials search

Paid Clinical Trials Arlington

Discover 1,917 paid clinical trials in Arlington, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Targeting Social Function in Anxiety and Eating Disorders

for
Eating Disorders, Anorexia Nervosa, Bulimia Nervosa,
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18 - 30

Code: NCT06198023

Recruiting

Hunger, Satiety, and Metabolic Responses to High-fat Meals of Varying Fatty Acid Composition

for
Body Weight Changes
Location: Fort Worth TX
Sponsor: Texas Christian University

Sex: Female

Age: 18 - 40

Code: NCT02966444

Recruiting

FlexHD® Pliable Investigation in Implant-Based Breast Reconstruction

for
Implant Based Breast Reconstruction
Location: Fort Worth TX
Sponsor: Musculoskeletal Transplant Foundation

Sex: Female

Age: 22+

Code: NCT06797258

Recruiting

A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors

for
Locally Advanced or Metastatic Solid Tumors, Colorectal Cancer,
Location: Irving TX, Houston TX, Denver CO, Sarasota FL,
Sponsor: ArriVent BioPharma, Inc.

Sex: All

Age: 18+

Code: NCT07066657

Phase1, Recruiting

Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.

for
Ovarian Cancer, Endometrial Cancer,
Location: Irving TX, Houston TX, Nashville TN, Orlando FL,
Sponsor: ArriVent BioPharma, Inc.

Sex: Female

Age: 18+

Code: NCT07755436

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Phase 1 Study of IM-1021 in Participants With Advanced Cancer

for
Solid Malignancies, Hematologic Malignancies
Location: Irving TX, Houston TX, San Antonio TX, Omaha NE,
Sponsor: Immunome, Inc.

Sex: All

Age: 18+

Code: NCT06823167

Phase1, Recruiting

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

for
Chronic Lymphocytic Leukemia
Location: Fort Worth TX, Branson MO, Germantown TN,
Sponsor: East Valley Hematology and Oncology Medical Group

Sex: All

Age: 18+

Code: NCT00131313

Recruiting

A Study of Olezarsen for the Treatment of Familial Chylomicronemia Syndrome (FCS) in Pediatric Participants

for
Familial Chylomicronemia Syndrome
Location: Fort Worth TX, Dallas TX, Birmingham AL,
Sponsor: Ionis Pharmaceuticals, Inc.

Sex: All

Age: 2 - 17

Code: NCT07727538

Phase3, Recruiting

The Unlocking PrEP Study: Integration of Peer Health Navigation Into Comprehensive Re-entry Services

for
HIV Disease, HIV Prevention
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18 - 70+

Code: NCT07292792

Recruiting

Study of Weekly ALTU-238 Compared With Daily Nutropin AQ in Prepubertal Children With Growth Hormone Deficiency

for
Growth Hormone Deficiency
Location: Ft. Worth TX, Little Rock AR, Kansas City MO,
Sponsor: Altus Pharmaceuticals

Sex: All

Age: 3 - 13

Code: NCT00837863

Phase2, Recruiting

Registry for Stage 2 Type 1 Diabetes

for
Type 1 Diabetes
Location: Fort Worth TX, Dallas TX, Austin TX, Houston TX,
Sponsor: Sanofi

Sex: All

Age: 0+

Code: NCT06481904

Recruiting

Phase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Involving the Central Nervous System

for
Herpes Simplex
Location: Fort Worth TX, Dallas TX, Houston TX, San Antonio TX,
Sponsor: National Center for Research Resources (NCRR)

Sex: All

Age: 0

Code: NCT00006132

Phase3, Recruiting

A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

for
Metabolic Dysfunction-associated Steatohepatitis
Location: Fort Worth TX, Farmers Branch TX, Forney TX,
Sponsor: Eccogene

Sex: All

Age: 18 - 70+

Code: NCT07288138

Phase2, Recruiting

Phase 1, Safety and Tolerability Study of XmAb541 and XmAb808 in Advanced Solid Tumors

for
Ovarian Cancer
Location: Fort Worth TX, Lake Success NY, New York NY,
Sponsor: Xencor, Inc.

Sex: Female

Age: 18+

Code: NCT07593092

Phase1, Recruiting

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)

for
Heart Failure
Location: Fort Worth TX, Denison TX, Austin TX, Texarkana TX,
Sponsor: Colorado Prevention Center

Sex: All

Age: 18+

Code: NCT06024746

Phase3, Recruiting

Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older

for
Respiratory Syncytial Virus Immunization,
Location: Irving TX, Dallas TX, Austin TX, Tomball TX, Houston TX,
Sponsor: Sanofi

Sex: All

Age: 60+

Code: NCT07734649

Phase1, Phase2, Recruiting

Post Approval Effectiveness and Durability Evaluation of the Altaviva™ Tibial Device

for
Urge Urinary Incontinence
Location: Arlington TX, St Louis MO, Homewood AL, Sioux Falls SD,
Sponsor: MedtronicNeuro

Sex: All

Age: 18+

Code: NCT07456865

Recruiting

A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).

for
Prostatic Hyperplasia
Location: Fort Worth TX, Mobile AL, Aurora CO, Stanford CA,
Sponsor: Milkhaus Laboratory

Sex: Male

Age: 45 - 70+

Code: NCT00044226

Phase2, Recruiting

Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)

for
Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD
Location: Arlington TX, Dallas TX, Tyler TX, Austin TX, Conroe TX,
Sponsor: Adverum Biotechnologies, Inc.

Sex: All

Age: 50+

Code: NCT07482176

Phase3, Recruiting

Safety, Tolerability, and Efficacy of AXA1125 in NASH With Fibrosis

for
Non Alcoholic Steatohepatitis (NASH)
Location: Arlington TX, Red Oak TX, Waco TX, Austin TX,
Sponsor: Axcella Health, Inc

Sex: All

Age: 18+

Code: NCT04880187

Phase2, Recruiting